Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
0.200
-0.002 (-0.89%)
At close: Dec 20, 2024, 4:00 PM
0.207
+0.007 (3.45%)
After-hours: Dec 20, 2024, 6:01 PM EST
Syros Pharmaceuticals Stock Forecast
SYRS's stock price has decreased by -96.45% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SYRS stock have an average target of 3.00, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 1,400.00% from the current stock price of 0.20.
Analyst Consensus: Hold
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for SYRS stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $6 → $1 | Strong Buy → Hold | Downgrades | $6 → $1 | +400.00% | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +2,900.00% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
459.00K
from 9.94M
Decreased by -95.38%
Revenue Next Year
5.10M
from 459.00K
Increased by 1,011.11%
EPS This Year
-1.58
from -5.81
EPS Next Year
-2.10
from -1.58
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.9M | 21.0M | 89.3M | |||
| Avg | 459,000 | 5.1M | 30.6M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -81.0% | 4,475.2% | 1,650.0% | |||
| Avg | -95.4% | 1,011.1% | 500.0% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.54 | -1.00 | -0.63 | |||
| Avg | -1.58 | -2.10 | -1.73 | |||
| Low | -1.64 | -3.12 | -2.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.